Latest disclosed trades
Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.
See the tradesUpdated Oct 17 · 2 feeds behind: Insider filings, 3 days, and 1 more · Every feed →
SYRE · $15K+ · 53 trades
Trades
53
Buys 0 · Sells 53
People
10
Stocks
1
Disclosed value
$1.6B
range midpoints · Congress & executive
Filed late
0
- ▼ SELLHeidy King-Jones InsiderSYRE Spyre Therapeutics, Inc.$1.4Mdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$732Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$216Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$35.6Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$326Kdisclosed Sep 3 · filed 2 days after the trade
- ▼ SELLJeffrey W. Albers DirectorSYRE Spyre Therapeutics, Inc.$1Mdisclosed Aug 10 · filed 3 days after the trade
- ▼ SELLJeffrey W. Albers DirectorSYRE Spyre Therapeutics, Inc.$835Kdisclosed Aug 10 · filed 3 days after the trade
- ▼ SELLJeffrey W. Albers DirectorSYRE Spyre Therapeutics, Inc.$522Kdisclosed Aug 10 · filed 3 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$221Kdisclosed Aug 5 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$681Kdisclosed Aug 5 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$75.2Kdisclosed Aug 5 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$486Kdisclosed Aug 5 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$541Kdisclosed Aug 5 · filed 2 days after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$135Kdisclosed Aug 5 · filed 2 days after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$152Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$506Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLSheldon Sloan Chief Medical OfficerSYRE Spyre Therapeutics, Inc.$569Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$52.5Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLSheldon Sloan Chief Medical OfficerSYRE Spyre Therapeutics, Inc.$162Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$890Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLCameron Turtle Chief Executive OfficerSYRE Spyre Therapeutics, Inc.$373Kdisclosed Jul 2 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$871Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLScott L Burrows Chief Financial OfficerSYRE Spyre Therapeutics, Inc.$436Kdisclosed Jun 26 · filed 1 day after the trade
- ▼ SELLMichael Thomas Henderson DirectorSYRE Spyre Therapeutics, Inc.$2Mdisclosed Jun 23 · filed 1 day after the trade
- ▼ SELLPeter Evan Harwin DirectorSYRE Spyre Therapeutics, Inc.$400Mdisclosed Jun 23 · filed the same day